- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03689491
The Combining rTMS With Visual Feedback Training for Patients With Stroke (rTMS)
Investigating the Effects of Combining rTMS With Visual Feedback Training to Improve Movements in the Paretic Lower Limb and Gait Performance
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To investigate the effects of combining rTMS with visual feedback training to improve movements in the paretic lower limb and gait performance.
Methods: Thirty patients with monohemispheric after ischemic stroke will recruited and randomized into 3 groups. The group 1 received a 10-minute rTMS intervention then a 30-minute visual feedback training. The group 2 received a 10-minute sham rTMS intervention then a 30-minute visual feedback training. The group 3 received a 10-minute sham rTMS intervention then a 30-minute traditional rehabilitation training. All subjects received treatments 3 times a week for 4 weeks. The performance was assessed by a blinded assessor for two times (baseline and after 4 weeks). The outcome measures included Motor evoked potential (MEP), Fugl-Meyer Assessment-Lower Limb section(FMA-LE),Motor Assessment Score(MAS), Berg Balance Test (BBS),Time Up and Go (TUG), and Modified Barthel Index for ADL ability. Collected data will be analyzed with ANOVA test by SPSS version 20.0, and alpha level was set at 0.05. The hypothesis is combining rTMS with visual feedback training has positive effects on lower limb and gait performance among patients with stroke.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan
- Taipei Medical University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Monohemispheric ischemic or hemorrhage stroke
- Subjects with first-ever stroke 3.6 months after stroke onset
4.The Brunnstrom stage of lower limb >Ⅲ 5.>23 in the mini-mental state exam 6.The Modified Ashworth Scale of lower limb <3 7.Clear consciousness can meet the relevant assessments
Exclusion Criteria:
- Recurrent stoke
- Severe spasticity of lower limb and difficult to perform isolative movement.
- History of seizures or epileptic
- Have implanted ferromagnetic devices or other magnetic-sensitive metal implants
- Concomitant vestibular and cerebellum diseases
- Joint contracture of lower limb/foot and other orthopedic problems
- Subjects with severe cognitive impairment
- Subjects with depression and/or mood disorder
- Presence of any comorbid neurological diseases or psychological diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: rTMS+visual feedback
10-minute rTMS and then a 30-minute visual feedback training ,3 times a week, for 4 weeks
|
The EMG measured the MEPs of the anterior tibialis in response to the TMS delivered using a Magstim Rapid2 stimulator (Magstim Co, Ltd, Carmarthenshire, Wales, UK) with a 70-mm figure-8 coil (maximum power, 2.2 T) over the contralateral M1.
The intensity was initially set at 100% of the machine output (MO) to determine the optimal stimulation site (hotspot).
The hotspot was marked on the scalp with oil ink and recorded as x, y, in centimeters from the vertex (cz).
The participants received real rTMS or sham rTMS, respectively (1 Hz, 10 min), which was before a 30-minute visual feedback training and/or traditional rehabilitation training.
Game-based visual feedback training system and software.The system was designed to enable the subjects to perform ankle movements in multiple axes.
|
Active Comparator: sham rTMS+visual feedback
10-minute sham rTMS and then a 30-minute visual feedback training ,3 times a week, for 4 weeks
|
The EMG measured the MEPs of the anterior tibialis in response to the TMS delivered using a Magstim Rapid2 stimulator (Magstim Co, Ltd, Carmarthenshire, Wales, UK) with a 70-mm figure-8 coil (maximum power, 2.2 T) over the contralateral M1.
The intensity was initially set at 100% of the machine output (MO) to determine the optimal stimulation site (hotspot).
The hotspot was marked on the scalp with oil ink and recorded as x, y, in centimeters from the vertex (cz).
The participants received real rTMS or sham rTMS, respectively (1 Hz, 10 min), which was before a 30-minute visual feedback training and/or traditional rehabilitation training.
Game-based visual feedback training system and software.The system was designed to enable the subjects to perform ankle movements in multiple axes.
|
Active Comparator: sham rTMS+traditional training
10-minute sham rTMS and then a 30-minute traditional rehabilitation training,3 times a week, for 4 weeks
|
The EMG measured the MEPs of the anterior tibialis in response to the TMS delivered using a Magstim Rapid2 stimulator (Magstim Co, Ltd, Carmarthenshire, Wales, UK) with a 70-mm figure-8 coil (maximum power, 2.2 T) over the contralateral M1.
The intensity was initially set at 100% of the machine output (MO) to determine the optimal stimulation site (hotspot).
The hotspot was marked on the scalp with oil ink and recorded as x, y, in centimeters from the vertex (cz).
The participants received real rTMS or sham rTMS, respectively (1 Hz, 10 min), which was before a 30-minute visual feedback training and/or traditional rehabilitation training.
30 min traditional rehabilitation.
The traditional rehabilitation programs included balance training, postural training, muscle strengthening, ambulation training and etc..
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Motor evoked potential
Time Frame: Change from baseline to 4 weeks
|
Measurement of motor evoked potential of anterior tibialis
|
Change from baseline to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chang of Motor Assessment Score
Time Frame: Change from baseline to 4 weeks
|
Lower Limb motor function
|
Change from baseline to 4 weeks
|
Chang of Berg Balance Test
Time Frame: Change from baseline to 4 weeks
|
standing balance
|
Change from baseline to 4 weeks
|
Chang of Fugl-Meyer Assessment-Lower Limb section
Time Frame: Change from baseline to 4 weeks
|
Lower Limb section
|
Change from baseline to 4 weeks
|
Chang of Modified barthel index
Time Frame: Change from baseline to 4 weeks
|
Activity of daily live ability
|
Change from baseline to 4 weeks
|
Chang of Time Up and Go
Time Frame: Change from baseline to 4 weeks
|
functional ambulation
|
Change from baseline to 4 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cheng Hsien-Lin, Master, Taipei Medical University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 105TMU-TMUH-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on rTMS
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
Chang Gung Memorial HospitalRecruiting
-
Changping LaboratoryBeijing HuiLongGuan HospitalRecruitingMajor Depressive Disorder | Severe Depression | Moderate DepressionChina
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre hospitalier de Ville-Evrard, FranceRecruitingTo Evaluate the Effectiveness of Open rTMSFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Changping LaboratoryWuhan Mental Health CentreRecruitingMajor Depressive Disorder | Severe Depression | Moderate DepressionChina
-
Stanford UniversityRecruitingMajor Depressive DisorderUnited States
-
Bayside HealthCompletedAutistic Disorder | Asperger's DisorderAustralia
-
Prof. Dominique de Quervain, MDRecruiting